Volume 23, Number 5—May 2017
Research Letter
Vertical Transmission of Zika Virus by Aedes aegypti and Ae. albopictus Mosquitoes
Table
Species/ population | Zika virus strain | Cycle | Blood meal titer, log10 PFU/mL | % Infected (diss)† | Mean body titer, log10 PFU/mL | Total no. pools | No. individual mosquitoes | dpi | Zika virus positive | FIR‡ (95% CI) |
---|---|---|---|---|---|---|---|---|---|---|
Ae. aegypti | ||||||||||
Mexico | ZIKV HND | All§ | 8.9 | 90.9 (95.0) | 7.6 | 26 | 130 | 11–18 | 1 | 7.7 (0.5–36.9) |
Argentina | ZIKV HND | All§ | 9.3 | 100 (100) | 6.6 | 28 | 136 | 11–38 | 2 | 14.9 (2.7–8.3) |
Combined¶ | ZIKV HND | OV2 | 29 | 141 | 11–22 | 1 | 7.1 (0.4–4.0) | |||
OV3 | 23 | 115 | 18–38 | 2 | 17.7 (3.2–57.2) | |||||
OV4 | 2 | 10 | 38 | 0 | <94.6 (6.6–495.8) | |||||
Combined¶ | ZIKV HND | All§ | 9.1# | 95.5 (97.5) | 7.4 | 54 | 266 | 11–38 | 3 | 11.5 (3.0–30.8) |
Argentina | ZIKV PR | OV1 | 24 | 120 | 36–38 | 2 | 17.0 (3.1–54.8) | |||
OV2 | 15 | 75 | 43–52 | 0 | <13.3 (0.8–63.6) | |||||
OV3 | 4 | 18 | 60–62 | 0 | <55.8 (3.4–262.5) | |||||
OV4 | 7 | 35 | 63 | 1 | 28.5 (1.7–34.8) | |||||
ZIKV PR | All§ | 9.1 | 100 (100) | 7.7 | 50 | 248 | 36–63 | 3 | 12.3 (3.3–33) | |
Combined |
Combined** |
All§ |
9.1# |
96.9 (98.3) |
7.5 |
104 |
514 |
11–63 |
6 |
11.9
(4.9–4.6) |
Ae. albopictus | ||||||||||
New York | ZIKV HND | All§ | 8.9 | 100 (93.3) | 7.1 | 17 | 85 | 11–63 | 1 | 11.8 (0.7–56.2) |
*Diss, disseminated; dpi, days post infection; FIR, filial infection rate; ZIKV HND, Zika virus Honduras 2016; OV, oviposition; ZIKV PR, Zika virus Puerto Rico.
†Percentage of infected with Zika virus–positive legs.
‡No. Zika virus positive/1,000 larvae.
§Combines data from all hatched eggs.
¶Data for both mosquito populations are combined.
#Mean titer.
**Data for both virus strains are combined.
Page created: April 17, 2017
Page updated: April 17, 2017
Page reviewed: April 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.